COYA vs LMT · rev $7.9M vs P/E 20, rev $20.06B
Coya Therapeutics, Inc. Common Stock (COYA) versus Lockheed Martin Corporation (LMT) — a side-by-side from cached financials, not a winner call.
Coya Therapeutics, Inc. Common Stock (COYA) is a biotechnology company listed on NASDAQ.
Lockheed Martin Corporation (LMT) is a aerospace & defense company listed on US. It is led by Jim Taiclet.
Latest reported COYA revenue for 2025-12-31 was $7.9M. Net income was -$21.2M. Revenue was up 123.6% from 2024-12-31 to 2025-12-31. COYA currently screens at market cap $118.0M.
Latest reported LMT revenue for 2026-06-28 was $20.06B. Net income was $1.84B. Revenue was up 11.3% from 2026-03-29 to 2026-06-28. LMT currently screens at market cap $108.37B and trailing P/E 19.9.
COYA currently screens at market cap $118.0M. LMT currently screens at market cap $108.37B and trailing P/E 19.9.
Not investment advice. Open the COYA and LMT stock pages for the full models.
Not investment advice.